Publication date: Jan 14, 2025 The neuroanatomical basis of white matter fiber tracts in gait impairments in individuals suffering from Parkinson’s Disease (PD) is unclear. Twenty-four individuals living with PD ... Read more

Publication date: Jan 15, 2025 Alpha-synuclein (ɑ-syn) plays a key role in Parkinson’s disease (PD) pathogenesis, but existing studies have found mixed results regarding the associations between plasma ɑ-syn and ... Read more

Publication date: Jan 10, 2025 Although inflammation and oxidative stress have been increasingly recognised as components of Alzheimer’s disease (AD) and Parkinson’s disease (PD) pathologies. Few studies have investigated peripheral ... Read more

Publication date: Jan 10, 2025 Cognitive impairment is a common nonmotor symptom among individuals with Parkinson’s disease (PD). Although cognitive impairment generally develops progressively, individuals with PD-associated mild cognitive impairment ... Read more

Publication date: Jan 10, 2025 We sought to characterize the cognitive profile among individuals with mild cognitive impairment with Lewy bodies (MCI-LB) to help guide future clinical criteria. Systematic review ... Read more

Publication date: Jan 07, 2025 Cognitive impairment in Parkinson’s disease (PD) substantially affects patient outcomes, function, and quality of life. PD-related cognitive dysfunction is often heterogeneous in clinical presentation and ... Read more

Publication date: Jan 06, 2025 Fall risk and cognitive impairment are prevalent and burdensome in Parkinson disease (PD), requiring efficacious, well-tolerated treatment. To evaluate the safety and efficacy of TAK-071, ... Read more